Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
90.96 EUR | -0.87% | +3.71% | +1.34% |
Mar. 28 | SANOFI : Barclays reiterates its Buy rating | ZD |
Mar. 28 | Smith & Nephew CFO designate John Rogers to start next week | AN |
Sales 2024 * | 46.44B 50.05B | Sales 2025 * | 50.22B 54.12B | Capitalization | 114B 122B |
---|---|---|---|---|---|
Net income 2024 * | 7.34B 7.91B | Net income 2025 * | 8.67B 9.35B | EV / Sales 2024 * | 2.6 x |
Net Debt 2024 * | 6.96B 7.5B | Net Debt 2025 * | 2.43B 2.62B | EV / Sales 2025 * | 2.31 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
12.8
x | Employees | 86,088 |
Yield 2024 * |
4.22% | Yield 2025 * |
4.57% | Free-Float | 87.77% |
Latest transcript on Sanofi
1 day | -0.87% | ||
1 week | +3.71% | ||
Current month | +3.49% | ||
1 month | +2.39% | ||
3 months | +1.90% | ||
6 months | -9.73% | ||
Current year | +1.34% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 19-08-31 |
Director of Finance/CFO | 59 | 18-09-30 | |
Nestle Frank
CTO | Chief Tech/Sci/R&D Officer | - | 16-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 14-04-30 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 20-05-21 |
Rachel Duan
BRD | Director/Board Member | 52 | 20-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.31% | 5 M€ | +4.56% | ||
3.66% | 129 M€ | -.--% | - | |
3.55% | 264 M€ | +13.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 90.96 | -0.87% | 1,839,942 |
24-03-27 | 91.76 | +0.50% | 1,234,665 |
24-03-26 | 91.3 | +1.84% | 1,589,467 |
24-03-25 | 89.65 | +1.13% | 1,169,107 |
24-03-22 | 88.65 | +1.07% | 1,869,167 |
Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.34% | 123B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |